Patents for C12R 1 - Micro-organisms (92,025) |
---|
10/13/1993 | EP0565370A1 Serotonin receptor protein and related DNA compounds |
10/13/1993 | EP0565172A1 Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity |
10/13/1993 | EP0565168A2 Purified enzyme concentrate and method of preparation |
10/13/1993 | EP0564965A2 Integrative gene-expression in food-grade microorganisms |
10/13/1993 | EP0564770A1 Diacetyl production |
10/13/1993 | EP0564620A1 Dermatomycosis vaccine |
10/13/1993 | EP0564539A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
10/13/1993 | EP0564532A1 Polypeptides derived from proteins of the hepatitis c virus |
10/13/1993 | EP0564479A1 Thiangazole, its preparation, compositions and use thereof |
10/13/1993 | EP0540687A4 Antibody-mediated cofactor-driven reactions |
10/12/1993 | US5252727 Heteropolysaccharide BM07 |
10/12/1993 | US5252483 Degradation of ferric chelates by a pure culture of agrobacterium sp. |
10/12/1993 | US5252481 Mutant of bacterium Clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase |
10/12/1993 | US5252480 Human monoclonal antibody and hybridoma producing the same |
10/12/1993 | US5252469 Process for producing a transglutaminase derived from streptomyces |
10/12/1993 | US5252468 Process for producing deacetylase from Vibrio cholerea IFO 15429 |
10/12/1993 | US5252465 Avian erythroblastosis virus vectors for integration and expression of heterologous genes in avian cells |
10/12/1993 | US5252329 Prophylaxis |
10/11/1993 | CA2093575A1 Human antithrombin iii mutant |
10/10/1993 | CA2093506A1 Serotonin receptor protein and related dna compounds |
10/08/1993 | CA2434692A1 Callus cell induction and the preparation of taxanes |
10/08/1993 | CA2093498A1 Complete gene (cefg) encoding the acetyl-coa: deacetylcephalosporin c acetyltransferase of cephalosporium acremonium, its isolation and use |
10/06/1993 | EP0564121A2 Formulation for the treatment of cancer comprising a bacterial extract |
10/06/1993 | EP0563714A2 TNF-Muteins |
10/06/1993 | EP0563527A1 Process for the detection of insertion elements or transposons |
10/06/1993 | EP0563383A1 (ganoderma lucidium) iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity |
10/06/1993 | EP0563346A1 Microbiological carboxylic acid production method. |
10/06/1993 | EP0563337A1 Manipulation of intestinal structure and enzymes in animals |
10/06/1993 | EP0563311A1 Improved vaccines |
10/06/1993 | EP0563198A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS |
10/06/1993 | EP0563175A1 A method of constructing synthetic leader sequences |
10/06/1993 | EP0563103A1 Enzymes and enzymatic detergent compositions |
10/06/1993 | EP0563089A1 Serotonine receptor of class 1: the 5-ht 1x? receptors |
10/06/1993 | EP0556345A4 Retroviral vectors useful for gene therapy |
10/06/1993 | EP0454778A4 Molecules with antibody combining sites that exhibit stereospecific catalysis |
10/06/1993 | CN1076966A Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
10/06/1993 | CN1076965A Novel fungal strains and use thereof in antibiotic production |
10/05/1993 | US5250435 Fermentation culture which produces high yields of pure reductase inhibitors or anticholesterol agents |
10/05/1993 | US5250428 L-gulono-gamma-lactone-dehydrogenase for producing vitamin C |
10/05/1993 | US5250425 Reacting ascorbic acid with phosphate donor in presence of Escherichia cells carrying recombinant DNA fragment coding for phosphorylating enzyme, recovering |
10/05/1993 | US5250423 Method for the production of L-lysine employing thermophilic corynebacterium thermoaminogenes |
10/05/1993 | CA1322735C Microorganism having low acetate forming capability, and process for production of useful substrate using same |
10/04/1993 | CA2092501A1 Method for biodegrading acrylic monomers and acrylic oligomers by microorganisms |
10/03/1993 | CA2091313A1 Tnf-muteins |
10/02/1993 | CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
09/30/1993 | WO1993019373A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
09/30/1993 | WO1993019372A1 Method of detecting microorganisms |
09/30/1993 | WO1993019200A1 TEST FOR $i(HELICOBACTER PYLORI) |
09/30/1993 | WO1993019197A1 Human monoclonal antibodies and methods for human monoclonal antibody production |
09/30/1993 | WO1993019196A1 ANTI-CD3 AGLYCOSYLATED IgG ANTIBODY |
09/30/1993 | WO1993019195A1 A process for producing heme proteins |
09/30/1993 | WO1993019194A1 Process for production of avermectins and cultures therefor |
09/30/1993 | WO1993019193A1 L-ascorbic acid enhanced biomass and its production |
09/30/1993 | WO1993019192A1 L-ascorbic acid production in microorganisms |
09/30/1993 | WO1993019191A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
09/30/1993 | WO1993019183A1 Immunization by inoculatioon of dna transcription unit |
09/30/1993 | WO1993019180A1 Genetically engineered antibodies |
09/30/1993 | WO1993019176A1 Leucine zippers |
09/30/1993 | WO1993019175A1 Receptor for the glucagon-like-peptide-1 (glp-1) |
09/30/1993 | WO1993019171A1 THERMOSTABLE XYLANASES FROM $i(THERMOTOGA) |
09/30/1993 | WO1993019170A1 Selection methods |
09/30/1993 | WO1993019162A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
09/30/1993 | WO1993019161A1 Method for producing high cell densities |
09/30/1993 | WO1993019089A2 Oxygen carrier |
09/30/1993 | WO1993018779A1 A strain of streptomyces avermitilis glycosylates avermectin compounds |
09/30/1993 | WO1993018654A1 Biological control of post-harvest diseases |
09/30/1993 | WO1993017093A3 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
09/30/1993 | WO1993016185A3 Biosynthetic binding protein for cancer marker |
09/30/1993 | WO1993016099A3 Dna sequences encoding novel growth/differentiation factors |
09/30/1993 | WO1993015203A3 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
09/30/1993 | WO1992001049A3 Cd53 cell surface antigen and use thereof |
09/30/1993 | DE4201050C1 New Lactobacillus sake strain - for curing raw sausage |
09/30/1993 | CA2132705A1 Biological control of post-harvest diseases |
09/30/1993 | CA2132345A1 Oxygen carrier |
09/30/1993 | CA2132299A1 A process for producing heme proteins |
09/30/1993 | CA2131790A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
09/30/1993 | CA2130173A1 Genetically engineered antibodies |
09/29/1993 | EP0562508A2 Protein with bone formation ability and process for its production |
09/29/1993 | EP0562313A1 Biochemical cleavage of organic C-S bonds |
09/29/1993 | EP0562206A2 Single-stranded DNA-RNA hybrid molecules and reverse transcriptases |
09/29/1993 | EP0562123A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine |
09/29/1993 | EP0562003A1 IMPROVED SACCHARIFICATION OF CELLULOSE BY CLONING AND AMPLIFICATION OF THE $g(b)-GLUCOSIDASE GENE OF TRICHODERMA REESEI |
09/29/1993 | EP0561953A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
09/29/1993 | EP0561890A1 Dna expression systems based on alphaviruses |
09/29/1993 | EP0480923B1 Method of producing proteins with fviii activity and/or fviii derivatives |
09/29/1993 | EP0353246B1 Sterol regulatory elements |
09/29/1993 | EP0334841B1 Micro-organisms and plasmids for producing 2,4-dichlorophenoxy acetic acid (2,4-d)-monooxygenase and process for producing these plasmids and strains |
09/29/1993 | EP0305481B1 Leader sequences for the production of recombinant proteins |
09/29/1993 | EP0245459B1 T-cell lymphotrophic virus protein and assay |
09/29/1993 | CA2133070A1 Vzhv 17.alpha.-hydroxy-3-methoxy-8, 14-seco-1,3,5(10),9(11)estratetraen-14-on |
09/28/1993 | US5248608 Enzyme catalyzed stereospecific hdyrolysis |
09/28/1993 | US5248607 Monoclonal antibodies and hybridomas specific for green-oat phytochrome |
09/28/1993 | US5248606 Dna encoding inactive precursor and active forms of maize ribosome inactivating protein |
09/28/1993 | US5248599 Genetic engineering, biosynthesis |
09/28/1993 | US5248500 Bacterial nematosides |
09/28/1993 | CA2092768A1 Protein with bone formation ability and process for its production |
09/24/1993 | WO1993019185A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine |
09/24/1993 | CA2132420A1 Recombinant antigen containing in its sequence a heterologous immuno-stimulatory domain-use as a vaccine |
09/23/1993 | DE4208429A1 Verfahren zur erzeugung hoher zelldichten Process for the production of high cell density |
09/22/1993 | EP0561525A1 Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use |